Corvus Pharmaceuticals, Inc. (CRVS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$15.58
Day's range
$16.48

Corvus Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 05/15/2026 7.17 M $104.82 M   0.00% 9.07%
BLACKROCK, INC. 05/13/2026 6.16 M $90.13 M   21.84% 7.80%
STATE STREET CORP 05/15/2026 3.57 M $52.17 M   27.89% 4.52%
ADAMS STREET PARTNERS LLC 05/15/2026 3.28 M $47.92 M   0.00% 4.15%
05/15/2026 3.23 M $47.32 M   100.00% 4.10%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 2.92 M $42.68 M   8,453.88% 3.69%
VIVO CAPITAL, LLC 05/20/2026 2.81 M $41.05 M   25.56% 3.55%
MORGAN STANLEY 05/15/2026 2.50 M $36.56 M   -29.96% 3.16%
DEEP TRACK CAPITAL, LP 05/15/2026 2.49 M $36.45 M   100.00% 3.16%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 2.32 M $33.92 M   636.78% 2.94%
PERCEPTIVE ADVISORS LLC 05/29/2026 2.29 M $33.54 M   231.07% 2.90%
COMMODORE CAPITAL LP 05/15/2026 2.26 M $33.05 M   100.00% 2.86%
FORESITE CAPITAL MANAGEMENT VI LLC 05/15/2026 1.83 M $26.79 M   32.58% 2.32%
BRAIDWELL LP 05/15/2026 1.75 M $25.64 M   100.00% 2.22%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.71 M $25.06 M   16.27% 2.17%
BIOIMPACT CAPITAL LLC 05/15/2026 1.67 M $24.50 M   -38.96% 2.12%
GOLDMAN SACHS GROUP INC 05/15/2026 1.54 M $22.54 M   178.46% 1.95%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 1.34 M $19.53 M   100.00% 1.69%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 1.10 M $16.09 M   100.00% 1.39%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.07 M $15.66 M   100.00% 1.36%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 891.93 K $13.05 M   100.00% 1.13%
MILLENNIUM MANAGEMENT LLC 05/15/2026 866.36 K $12.67 M   25.78% 1.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 750.00 K $10.97 M   100.00% 0.95%
EMERALD ADVISERS, LLC 05/04/2026 686.22 K $10.04 M   100.00% 0.87%
05/08/2026 669.90 K $9.80 M   100.00% 0.85%
DCF ADVISERS, LLC 05/11/2026 637.50 K $9.33 M   -12.55% 0.81%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 550.00 K $8.05 M   100.00% 0.70%
MARSHALL WACE, LLP 05/15/2026 548.29 K $8.02 M   153.54% 0.69%
BLUE OWL CAPITAL HOLDINGS LP 05/14/2026 545.00 K $7.97 M   100.00% 0.69%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 543.40 K $7.95 M   57.92% 0.69%
TWO SIGMA INVESTMENTS, LP 05/15/2026 539.87 K $7.90 M   275.96% 0.68%
NORTHERN TRUST CORP 05/14/2026 506.10 K $7.40 M   17.76% 0.64%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 504.63 K $7.38 M   100.00% 0.64%
EMERALD MUTUAL FUND ADVISERS TRUST 05/04/2026 459.25 K $6.72 M   100.00% 0.58%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 450.00 K $6.58 M   100.00% 0.57%
NEXTECH INVEST, LTD. 05/15/2026 450.00 K $6.58 M   100.00% 0.57%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 450.00 K $6.58 M   -10.00% 0.57%
CITADEL ADVISORS LLC 05/15/2026 442.52 K $6.47 M   112.57% 0.56%
UBS GROUP AG 05/05/2026 289.11 K $4.23 M   36.37% 0.37%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2026 278.01 K $4.07 M   100.00% 0.35%
CITADEL ADVISORS LLC 05/15/2026 267.80 K $3.92 M   185.50% 0.34%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 247.96 K $3.63 M   -39.18% 0.31%
DIADEMA PARTNERS LP 05/15/2026 244.81 K $3.58 M   100.00% 0.31%
BARCLAYS PLC 05/15/2026 243.78 K $3.57 M   -38.25% 0.31%
BANK OF AMERICA CORP /DE/ 05/18/2026 237.00 K $3.47 M   0.22% 0.30%
05/14/2026 231.59 K $3.39 M   100.00% 0.29%
05/07/2026 226.84 K $3.32 M   100.00% 0.29%
JANE STREET GROUP, LLC 05/12/2026 217.80 K $3.19 M   462.79% 0.28%
CITADEL ADVISORS LLC 05/15/2026 202.40 K $2.96 M   15.66% 0.26%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 188.13 K $2.75 M   9.91% 0.24%

Corvus Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 208 institutional investors and hedge funds held shares of Corvus Pharmaceuticals Inc. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 7.17 M

BlackRock, Inc.: 6.16 M

STATE STREET CORP: 3.57 M

ADAMS STREET PARTNERS LLC: 3.28 M

PRICE T ROWE ASSOCIATES INC /MD/: 2.92 M

Vivo Capital, LLC: 2.81 M

88.61% of Corvus Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 72.25 M shares in the last 24 months. This purchase volume represents approximately $1.15 B in transactions.